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Possible role of gnih as a Mediator 
between adiposity and impaired 
Testicular Function
Shabana Anjum1 , Amitabh Krishna1* and Kazuyoshi Tsutsui2
1 Department of Zoology, Banaras Hindu University, Varanasi, India, 2 Department of Biology, Waseda University, Tokyo, Japan
The aim of the present study was to evaluate the roles of gonadotropin-inhibitory hor-
mone (GnIH) as an endocrine link between increasing adiposity and impaired testicular 
function in mice. To achieve this, the effect of GnIH on changes in nutrients uptake 
and hormonal synthesis/action in the adipose tissue and testis was investigated 
simultaneously by in vivo study and separately by in vitro study. Mice were treated 
in vivo with different doses of GnIH for 8 days. In the in vitro study, adipose tissue and 
testes of mice were cultured with different doses of GnIH with or without insulin or LH 
for 24 h at 37°C. The GnIH treatment in vivo showed increased food intake, upregu-
lation of glucose transporter 4 (GLUT4), and increased uptake of triglycerides (TGs) 
in the adipose tissue. These changes may be responsible for increased accumulation 
of fat in white adipose tissue, resulting in increase in the body mass. Contrary to 
the adipose tissue, treatment with GnIH both in vivo and in vitro showed decreased 
uptake of glucose by downregulation of glucose transporter 8 (GLUT8) expressions in 
the testis, which in turn resulted in the decreased synthesis of testosterone. The GnIH 
treatment in vivo also showed the decreased expression of insulin receptor protein 
in the testis, which may also be responsible for the decreased testicular activity in 
the mice. These findings thus suggest that GnIH increases the uptake of glucose 
and TGs in the adipose tissue, resulting in increased accumulation of fat, whereas 
simultaneously in the testis, GnIH suppressed the GLUT8-mediated glucose uptake, 
which in turn may be responsible for decreased testosterone synthesis. This study 
thus demonstrates GnIH as mediator of increasing adiposity and impaired testicular 
function in mice.
Keywords: gnih, adipose tissue, testis, glUT4, glUT8
inTrODUcTiOn
Nutrition has a significant impact on reproductive processes, including steroidogenesis, gametogen-
esis, early embryonic development, etc. (1, 2). This association is because reproductive activities are 
energetically expensive, and the brain modulates the reproductive processes according to nutritional 
availability (3, 4). The reproductive tissues appears to have a number of “nutrient sensing” mecha-
nisms that may link nutrient status to the reproductive system. Glucose is a very important mediator 
of nutritional effects on reproduction. Blood concentrations are inversely correlated to energy intake 
(5). Glucose is transported by the family of facilitative glucose transporters (GLUTs), which are 
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involved in hypothalamic regulation (6, 7). Glucose also plays a 
major role in providing metabolic substrates to germ cells in the 
gonads (8, 9). GLUTs in cells act as glucose sensors. Glucose avail-
ability influences lutienizing hormone (LH) secretion through 
gonadotropin-releasing hormone (GnRH) system (10). Insulin is 
a modulator of the metabolic stimulus and plays crucial roles in 
the relationship between changes in nutritional levels and repro-
duction (11). The anabolic actions of insulin on peripheral tissues 
are well established and plasma insulin also serves as a signal of 
body fat content to the central nervous system (12). Insulin also 
amplifies the lipogenesis in adipose tissue (13). Glucose is made 
available in the body by insulin, which helps to lower the level of 
circulating glucose by promoting its uptake either in adipose tis-
sue or muscle cells through GLUT4 (14). In the gonads, glucose is 
essential for maintenance of spermatogenesis in vivo (15, 16). The 
isoforms of GLUTs are expressed in the testis (17). GLUT8 appears 
to be one of the main GLUTs in the testis (18). Furthermore, it has 
been demonstrated that adequate amount of GLUT is required 
for proper testicular activity (18). Insulin has a direct effect at 
the testis level (16). Insulin receptors (IR) are expressed in both 
somatic cells, such as Leydig, Sertoli, and peritubular cells, and 
germ cells in the testis of various vertebrate species (19). IR signal 
through the IR substrate proteins (IRS) (20, 21) plays a role in 
regulating fertility under normal fed conditions.
Adipose tissue is the main organ in the body that provides 
a storage site for triglycerides (TGs) and deals with energy 
homeostasis. Serum glucose is taken up and stored as fatty acid 
via lipogenesis in adipocytes, whereas the fall in glucose levels 
stimulates lipolysis, leading to release of TGs/fatty acid. Mature 
adipocytes synthesize and secrete numerous hormones called 
adipokines, which are involved in overall energy homeostasis and 
also modulate reproductive activities. Recent studies have shown 
a negative relationship between adiposity and testicular func-
tion (22, 23). Although a more recent study suggested a strong 
association between metabolic disorders and infertility (24), the 
factors mediating the influence of nutrition on reproduction are 
currently not clearly known and require detailed investigation.
The neural elements within the brain that control nutritional 
function and those that control reproduction are interconnected. 
Thus, studies are required to understand how the neural system 
that affects food intake may impact on reproductive function. As a 
generalization, neuropeptides that stimulate reproduction inhibit 
food intake and vice versa. Central (neuroendocrine) regulation 
of both reproduction and nutritional function provides a meas 
whereby surplus energy or energy deficit can be perceived, 
and accordingly, food intake and energy expenditure can be 
modulated (25). In 2000, a novel hypothalamic neuropeptide that 
actively inhibits gonadotropin release was discovered in quail and 
termed gonadotropin-inhibitory hormone (GnIH) (26). GnIH 
has a C-terminal Arg–Phe–NH2 (RFamide) motif and acts via 
GnIH receptor (GnIHR), a new member of G-protein coupled 
receptor superfamily (GPR147), to inhibit gonadotropin release 
and synthesis (27, 28). The follow-up studies demonstrated that 
GnIH acts as a new key player for regulation of reproduction in 
birds and mammals (27, 28). GnIH is one of the RFamide pep-
tides, and it is also known as RFamide-related peptide (RFRP) in 
mammals (27, 28). It is known that GnIH acts on gonadotropes in 
the anterior pituitary and GnRH neurons in the hypothalamus to 
inhibit gonadotropin release and synthesis via GnIHR (GPR147) 
in birds and mammals (27–29). Recent evidence further indicates 
that GnIH operates at the level of the gonads as an autocrine/
paracrine regulator of steroidogenesis and gametogenesis in birds 
and mammals (27–29).
Recent studies suggested an inverse relationship between 
increasing adiposity with regressive changes in testis (22, 30). The 
factors responsible for regulating the inverse association between 
obesity and testicular activity are not yet known. GnIH is shown 
to have dual function: it suppresses reproductive activity while 
promoting fat accumulation by acting as an orexigen in birds 
and mammals (31–33). It is thus possible that GnIH may be the 
endocrine mediator between nutritional changes associated with 
adiposity and changes in the reproductive status. If above hypoth-
esis is true, the GnIH should regulate food intake and promote 
accumulation of fat in adipose tissue; at the same time, it should 
exert inhibitory effect on testicular function. Therefore, the aim 
of this study was to determine the role of GnIH as a modulator 
of both testes (testosterone synthesis) as well as adipose tissue 
(accumulation of fat) function. This was achieved by investigating 
the effect of GnIH on changes in nutrients uptake and hormonal 
synthesis/action in the testis and adipose tissue simultaneously by 
in vivo study and separately by in vitro study.
MaTerials anD MeThODs
animal
Adult Parkes strain male laboratory mice (Mus musculus) were 
obtained from the inbred colony maintained in our animal house. 
All experiments were conducted in accordance with principles 
and procedures of the 2002 Animal act, India, and approved by 
Animal Ethical Committee, Banaras Hindu University. The adult 
mice (13 weeks old) of nearly equal body weight (approximate 
body weight = 30 g) were used in this study. Mice were housed 
under optimum conditions of temperature 24 ± 2°C and humidity 
50 ± 5% in a photoperiodically controlled room (12-h light:12-h 
dark) and were provided with commercial food (Pashu Aahar 
Kendra, Varanasi, India) and tap water ad libitum.
chemicals
GnIH or mRFRP-3 (SIKPSAYLPLRF-NH2) was synthesized by 
Son et al. (34). Insulin was obtained from torrent Pharmaceuticals 
Ltd., Mehsana, India. Antibodies to IR β-subunit, GLUT4, 
and GLUT8 were purchased from Santa Cruz Biotechnology 
(Santa Cruz, CA, USA), and protein kinase B (PKB)/AKT was 
purchased from GeneScript USA Inc. (Piscataway, NJ, USA). All 
other chemicals were purchased from Merck, New Delhi, India. 
The specificity of antibodies is shown in Table 1.
In Vivo study
Mice were injected daily with three different doses (20, 200 ng, and 
2 μg/day) of GnIH dissolved in normal saline for 8 days (n = 10 
per group), intraperitoneally. Mice in the control group received 
vehicle only. The dose and duration of GnIH was selected based 
on the previous study (31). Food intake was measured at every 
TaBle 1 | Details of antibodies used for Western blot.
antibody Target species species raised in;  
monoclonal/polyclonal
source concentration (used for 
Western blot)
GLUT4 Human Rabbit; polyclonal Santa cruz Biotechnology Inc.  
(H-61, SC 7938)
1:500
GLUT8 Human Rabbit; polyclonal Santa cruz Biotechnology Inc.  
(N-60, SC 30108)
1:500
Insulin receptor β Human Rabbit; polyclonal Santa cruz Biotechnology Inc.  
(C-19, SC 711)
1:500
AKT Human Rabbit; polyclonal GeneScript Inc. (A00965-40) 1:200
Actin β-Actin Mouse; monoclonal Sigma A2228, 128K4813 1:2000
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24 h. The animals were sacrificed by decapitation under a mild 
dose of anesthetic ether, 24 h after the last injection, and blood 
was collected. Body mass of each mouse was recorded before kill-
ing. Testes and adipose tissue were excised out, cleaned, weighed, 
and kept at −40°C for immunoblot analysis. The adipose tissue 
accumulated in the abdominal cavity region of the control and 
treated mice were excised out and weighed. Serum was collected 
and stored at −20°C untill testosterone assay, glucose assay, and 
TG assay.
Food intake Measurement
All mice were individually housed in standard polypropylene cage 
with hopper style feeder, for lab blocks keep food waste mini-
mum and wood shavings scattered on the floor. Each mouse was 
provided with measured amount (25 g) fresh mice feed between 
1,000 and 1,100 h daily for 8 days, and the leftover food pellets 
(excluding fecal matter) were weighed at the end of 24  h. The 
total food consumed by each mouse every day was calculated by 
subtracting the weight of leftover food from the total amount of 
food given. From the individual data, average food consumed by 
the control and treated group were subsequently calculated. The 
average food consumption was measured on day first, fourth, and 
eight of the experiment. Average daily food intake was calculated 
as sum of the average food intake on day first, fourth, and eight 
and divided by three. The amount of food intake by each mouse 
showed not much change up to day third, but from day fourth 
up to day eighth, mice the treated with GnIH showed marked 
increase. Generally, the mouse consumed more food during night 
as comparable to day. The control mouse showed no significant 
change in food intake throughout the study.
In Vitro study
Testis Culture
Adult testes (n = 8 testes) were quickly dissected out and cleaned 
of any adhered fat tissue in Dulbecco modified Eagle’s medium 
(DMEM; Himedia, Mumbai, India) containing 250 IU/ml peni-
cillin and 250  mg/ml streptomycin sulfate. The testes were cut 
into equal pieces (approximate 10 mg in weight) and cultured by 
the method as described previously (35). Culture medium was 
a mixture of DMEM (with sodium pyruvate and l-glutamine) 
and Ham’s F-12 (1:1; v:v) (Himedia, Mumbai, India) containing 
100 U/ml penicillin, 100 μg/ml streptomycin, and 0.1% bovine 
serum albumin (BSA; Sigma, St Louise, MO, USA). After initial 
incubation for 2 h at 37°C, culture medium was discarded, and 
testicular slices (1 per tube) were finally cultured in 1-ml medium 
containing 10−10 and 10−9M/ml GnIH along with or without 
10 and 100  ng/ml luteinizing hormone (LH) in a humidified 
atmosphere with 95% air and 5% CO2 to maintain pH 7.4 for 
24 h at 37°C. The doses of GnIH and LH used for the in vitro study 
were selected from our previous study (31, 36). Testes cultured 
under these conditions appear healthy and do not show any sign 
of necrosis. Each treatment group was run in triplicate. This is 
evaluated by Autospan liquid gold-Lactate dehydrogenase (Surat, 
Gujarat, India) in culture media after 2 h of incubation at 37°C. 
Testicular slices were collected at the end of culture, washed sev-
eral times with PBS, and stored at −40°C for immunoblot study, 
and media were collected, stored at −40°C until testosterone 
assay and glucose uptake (35).
Adipocytes Culture
White adipose tissue (WAT) collected from abdominal cavity of 
adult male mouse (n = 6) was used to determine the in vitro effects 
of GnIH with or without insulin on GLUT4, IR, and AKT/PKB 
protein expression in WAT of male mouse. The dose and duration 
of RFRP-3 was selected based on previous study (37). We assayed 
these biochemical markers at three doses of insulin. Culture meth-
ods for WAT were adopted according to Roy and Krishna (38). 
Following collection, WAT was quickly cut into pieces in DMEM 
(Himedia, Mumbai, Maharashtra, India) containing 250  IU/ml 
penicillin and 250 mg/ml streptomycin sulfate. Pieces of WAT of 
equal mass were cultured in a mixture of DMEM (with sodium 
pyruvate and l-glutamine) and Ham’s F-12 (1/1 v/v) (Himedia) 
containing 100  IU/ml penicillin, 100 mg/ml streptomycin, and 
0.1% BSA (Sigma, St Louise, MO, USA). After initial incubation 
for 2 h at 37°C, the culture medium was discarded, and pieces of 
WAT were cultured in 1-ml medium containing either 1, 5, or 
10 μg/ml insulin or 10 ng/ml GnIH in a humidified atmosphere 
with 95% air and 5% CO2 to maintain pH 7.4 for 24 h at 37°C. 
Each treatment group was run in triplicate. After culture, WAT 
was collected, washed several times with phosphate buffer saline 
(PBS), and kept frozen at −40°C until immunoblot assay, and 
media were collected, stored at −40°C until glucose uptake (38).
immunoblot
The testes and WATs collected at the end of in vivo and in vitro 
studies were processed for protein extraction using the method 
described earlier (39, 40). Western blot analysis was performed as 
TaBle 2 | effect of gnih on average daily food intake in mice (in vivo).
Doses of 
gnih
Daily food intake (g) average daily 
food intake (g)
Day 1 Day 4 Day 8
Control 18.4 ± 0.095 18.1 ± 0.170 17.8 ± 0.105 18.1 ± 0.173
20 ng/day 17.08 ± 0.04 16.2 ± 0.138 17.8 ± 0.084 17.05 ± 0.482
200 ng/day 18.01 ± 0.28 22.40 ± 0.44* 24.55 ± 0.183* 21.32 ± 1.69*
2 μg/day     22 ± 0.219* 24.55 ± 0.131* 25 ± 0.002* 23.85 ± 0.93*
Values are mean ± SEM for five animals (daily food intake).
*Significantly different from controls (p < 0.05) by one-way analysis of variance 
(ANOVA) followed by Bonferroni’s test.
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previously described (38). In short, a 20% homogenate (w/v) of adi-
pose tissue was made in suspension buffer containing 0.1M NaCl, 
0.01M Tris–HCl (pH 7.6), 0.001M EDTA (pH 8.0), and 10 μg/ml 
phenylmethylsulfonyl fluoride. The homogenate was centrifuged 
at 5,000 g and at 4°C for 15 min; the supernatant was extracted 
with an equal volume of chloroform and the aqueous phase was 
recovered. Equal amounts of proteins (40 μg) as determined by 
Folin’s method were used for 10% SDS-PAGE. Thereafter, pro-
teins were transferred electrophoretically to a PVDF membrane 
(Millipore India Pvt. Ltd., Bangalore, Karnataka, India) overnight 
at 4°C. Membranes were blocked for 1 h with Tris-buffered saline 
[TBS; Tris 50  mM (pH 7.5), NaCl 150  mM, 0.02% Tween 20] 
containing 5% fat-free dry milk. The membranes were further 
incubated with primary antibody (see Table 1) for 1 h in block-
ing solution. Immunodetection was performed with anti-rabbit 
IgG conjugated horseradish peroxidase (1:1,000) for 4 h. Finally, 
the blot was washed three times with TBS and developed with an 
enhanced chemiluminescence (ECL) detection system (Bio-Rad, 
Hercules, CA, USA). Similarly, a blot was developed for β-actin 
(Sigma-Aldrich, India) at a dilution of 1:1,000 as a loading con-
trol. Immunoreactive bands were later quantified using Image J 
software (Image J 1.36, NIH, Bethesda, MD, USA) (38).
Testosterone assay
Testosterone was measured by using ELISA kit purchased from 
Dia Metra, Giustozzi, Foligno (PG) Italy (LOT No: DKO002) as 
described earlier (31). The 25 μl of standard, control, or sample 
and 100  μl of diluted conjugate solution were added to each 
ELISA plate. The ELISA plate was then incubated at 37°C for 1 h 
with mild shaking. The wells were aspirated and washed several 
times with distilled water. After adding 100 μl of the tetramethyl 
benzidine (TMB) chromagen substrate to each well, ELISA plate 
was incubated at room temperature for 15 min in the dark. Finally, 
stop solution (100 μl) was added, and absorbance was recorded 
at 450 nm using a microplate reader. The standard curve ranged 
from 0.2 to 16 ng/ml (31).
Glucose Assay
Blood glucose was measured by the glucose oxidase method 
using a commercially available automated glucose analyzer (Span 
Diagnostics Ltd., Surat, Gujarat, India) with 10 μl of blood.
serum Triglyceride assay and adipose 
Tissue Triglyceride content
Triglyceride in blood was measured using a commercially avail-
able colorimetric kit (GPO-Trinder) (Span Diagnostics Ltd., 
Surat, Gujarat, India), and TG in WAT was measured with minor 
modifications (41, 42). A 20% homogenate (w/v) of WAT was 
prepared in PBS. Then TG was extracted from the homogenate 
overnight in heptane:isopropanol (3:2) at 4°C. TG content was 
measured using a colorimetric kit (GPO-Trinder) from Span 
Diagnostics Ltd., Surat, Gujarat, India. Results are expressed as 
milligram TG per milligram protein.
glucose Uptake assay: In Vitro study
The media stored at −20°C was used for glucose uptake assay 
according to Roy and Krishna (38) and Banerjee et  al. (16), 
who described earlier to determine the glucose by quantitative 
colorimetric method. The glucose concentration of the media was 
measured at the beginning as well as at the end of culture, and 
the difference between initial concentration of media and final 
concentration of media after the 24 h culture was taken as the 
amount of glucose uptake by the WAT or testis. Each group was 
run in triplicates. The intra-assay coefficient of variation (CV) 
was <7.5%.
statistical analysis
Data were analyzed using one-way ANOVA followed by 
Bonferroni’s test using SPSS software 16 for Windows (SPSS Inc., 
Chicago, IL, USA). Correlation studies were performed to com-
pare data from different groups. The differences were considered 
significant at the level of p < 0.05.
resUlTs
changes in Daily Food intake
Table  2 shows the effect of in  vivo administration of GnIH 
on food intake of adult male mice. Three different doses 
(20, 200  ng, and 2 μg/day) of GnIH administration caused a 
dose-dependent increase in food intake. A significant increase 
(p <  0.05) in food intake was noticed in mice treated with a 
high dose (2 μg/day) of GnIH for 8 days as compared with the 
control.
Body Mass and adipose Tissue Mass
The body mass showed significant (p < 0.05) increase by the treat-
ment with moderate and high doses (200  ng and 2 μg/day) of 
GnIH as compared with the control. The adipose tissue mass also 
changed in response to the treatment with different doses (20, 
200 ng, and 2 μg/day) of GnIH. The adipose tissue mass showed 
no significant change when treated with a low dose (20 ng/day) of 
GnIH, whereas it increased significantly (p < 0.05) in response to 
moderate and high doses of GnIH treatments as compared with 
the control (see Table 3).
circulating Triglyceride, glucose, and 
Testosterone levels
The treatment with different doses (20, 200  ng, and 2 μg/day) 
of GnIH showed significant variation in circulating levels of 
TG s (p < 0.05) and glucose (p < 0.05). Both TG s and glucose 
TaBle 3 | effect of gnih on body mass, WaT mass, adipose tissue Tg, testicular glucose, serum Tg, and serum glucose mice (in vivo).
Doses of 
gnih
Body mass 
(g)
White adipose 
tissue mass (g)
Tissue serum 
adipose tissue Triglyceride 
concentration (Tg/mg protein)
Testicular glucose concentration 
(mg/mg testis wt)
Triglyceride 
level (mg/dl)
glucose level 
(mg/dl)
Control 33.258 ± 0.23 2.121 ± 0.10 442.8 ± 5.34 4.4 ± 0.166 140.38 ± 1.58 43.86 ± 1.68
20 ng/day 33.022 ± 0.56 1.524 ± 0.04 179.8 ± 3.32* 3.8 ± 0.12 229.25 ± 2.01* 85.65 ± 1.49*
200 ng/day 34.236 ± 0.30 2.88 ± 0.08* 256.56 ± 10.86* 3.2 ± 0.176* 196.57 ± 1.43* 65.33 ± 1.85*
2 μg/day 38.89 ± 0.38* 3.22 ± 0.05* 602.65 ± 5.85* 2.5 ± 0.17* 93.36 ± 4.13* 31.65 ± 1.43*
Values are mean ± SEM for five animals.
*Significantly different from controls (p < 0.05) by one-way analysis of variance (ANOVA) followed by Bonferroni’s test.
FigUre 1 | The mice treated with different doses (20, 200 ng, and 
2 μg/day) of gnih on synthesis of testosterone in testis of mice. GnIH 
showed significantly decreased (p < 0.05) synthesis of testosterone levels in 
dose-dependent manner as compare to control (a, p < 0.05).
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levels were significantly (p < 0.05) increased in response to low 
and moderate doses (20 and 200 ng/day) of GnIH treatment as 
compared with the control. However, both TGs and glucose levels 
were significantly (p < 0.05) decreased with a high dose (2 μg/day) 
of GnIH in comparison to the control (Table 3). The treatment 
with different doses of GnIH showed a significant (p < 0.05) dose-
dependent decline in circulating testosterone levels as compared 
with the control (Figure 1).
changes in the level of Triglycerides 
and in the expression of glUT4 and 
glUT8 and ir Proteins in the adipose 
Tissue
The treatment with low and moderate doses (20 and 200 ng/day) 
of GnIH showed significant decrease (p < 0.05) in the TG level 
in the adipose tissue, whereas a high dose (2 μg/day) of GnIH 
treatment showed a significant increase (p <  0.05) in the TGs 
level in the adipose tissue as compared with the control (p < 0.05) 
(Table 3).
The treatment with low dose (20 ng/day) of GnIH showed sig-
nificant (p < 0.05) increase in the expressions of IR and GLUT8 pro-
teins in the adipose tissue as compared with the control. However, 
moderate and high doses (200 ng and 2 μg/day) of GnIH showed 
significant (p <  0.05) decreased expressions of IR and GLUT8 
proteins as compared with the control (Figures  2A,B). A low 
dose (20 ng/day) of GnIH treatment showed significant (p < 0.05) 
decreased expression of GLUT4 whereas a high dose (2 μg/day) 
showed significant (p < 0.05) increased expression of GLUT4 as 
compared with the control in the adipose tissue (Figure 2C).
changes in the level of glucose and in 
the expression of glUT8 and ir Proteins 
in the Testis
The treatment with low and moderate doses (20 and 200 ng/day) 
of GnIH showed significant (p < 0.05) decrease in glucose con-
centrations in the testis as compared with the control. Whereas 
the treatment with a high dose (2 μg/day) caused a significant 
(p < 0.05) increase in glucose level in the testis as compared to 
treatment with the moderate dose (Table 3).
The treatment with low and moderate doses of GnIH showed 
significant (p < 0.05) decrease in expression of IR protein in the 
testis as compared with the control, whereas the treatment with a 
high dose caused a significant (p < 0.05) increase in the expres-
sion of IR protein as compared with the moderate dose treatment 
(Figure 3A).
The treatment with a moderate dose (200  ng/day) of GnIH 
showed a significant (p <  0.05) decrease in the expression of 
GLUT8 protein in the testis as compared with the control, whereas 
the treatment with a high dose (2 μg/day) caused a significant 
(p < 0.05) increase in expression of GLUT8 protein in the testis as 
compared with the moderate dose treatment (Figure 3B).
effects of In Vitro Treatment of gnih with 
or without lh in the Testis of Mice
Effect on Glucose Uptake
The in vitro treatment with low and high doses (10−10 and 10−9M/
ml) of GnIH showed a dose-dependent suppression of glucose 
uptake in the testis. The treatment with low and high (10 and 
100 ng/ml) doses of LH alone showed a dose-dependent signifi-
cant (p < 0.05) increase in glucose uptake by the testis. The treat-
ment with a high dose of LH together with a high dose of GnIH 
showed a significant (p < 0.05) increase in uptake of glucose by 
the testis as compared with the control (Figure 4A).
Effect on the Expression of GLUT8 Protein
The in  vitro treatment with low and high doses (10−10 and 
10−9M/ml) of GnIH showed a significant (p < 0.05) decrease in 
the expression of GLUT8 protein. However, the in vitro treatment 
FigUre 3 | The densitometric analysis of the Western blot showed 
the treatment of different doses (20, 200 ng, and 2 μg/day) of gnih on 
expression of ir and glUT8 proteins in testis of mice. (a) The 
treatment with low and moderate doses (20 and 200 ng/day) of GnIH 
showed significant (b and c, p < 0.05) decrease in expression of IR protein as 
compared with the control, whereas high dose (2 μg/day) caused a 
significant (d, p < 0.05) increase in the expression of IR protein as compared 
with the control and moderate dose treatment. (B) The treatment with a low 
and moderate dose (20 and 200 ng/day) of GnIH showed a significant (b and 
c, p < 0.05) decrease in the expression of GLUT8 protein as compared with 
the control, whereas the treatment with a high dose (2 μg/day) caused a 
significant (d, p < 0.05) increase in the expression of GLUT8 protein as 
compared with the moderate dose treatment. Values are mean ± SEM.
FigUre 2 | The densitometric analysis of the Western blot showed 
the treatment of different doses (20, 200 ng, and 2 μg/day) of gnih on 
expression of ir, glUT8, and glUT4 proteins in adipose tissue of 
mice. (a) GnIH showed a dose-dependent significant (p < 0.05) decline in 
the expression of IR. Moderate and high doses of GnIH (200 ng and 2 μg/
day) showed significant (b and c, p < 0.05) decrease in the expression of IR 
protein as compare with control (a, p < 0.05). (B) A low dose of GnIH (20 ng/
day) showed significant (b, p < 0.05) increased in the expression of GLUT8 
protein as compared to the control. However, moderate and high doses of 
GnIH (200 ng and 2 μg/day) showed significant (c and d, p < 0.05) decrease 
in the expression of GLUT8 protein as compare with control (a, p < 0.05). 
 (c) A low dose (20 ng/day) of GnIH treatment showed significant (p < 0.05) 
decrease in the expression of GLUT4 whereas a high dose (2 μg/day) 
showed significant (p < 0.05) increase in the expression of GLUT4 as 
compared with the control in the adipose tissue. Values are mean ± SEM.
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with low and high doses (10 and 100  ng/ml) of LH showed a 
dose-dependent significant (p < 0.05) increase in the expression 
of GLUT8 protein. The in vitro treatment with a high dose of LH 
with a high dose of GnIH showed a significant increase in the 
expression of GLUT8 protein in the testis as compared with the 
control (Figure 4B).
effects of In Vitro Treatment of insulin to 
the adipose Tissue of Mice
Effects on the Expressions of IR, GLUT4, and AKT 
Proteins in the Adipose Tissue
The adipose tissue treated in vitro with 1, 5, and 10 μg/ml doses 
of insulin showed dose-dependent significant (p < 0.05) increase 
in expression of IR, GLUT4 proteins in the adipose tissue as 
compared with the control (Figures 5A,B).
The adipose tissue treated in vitro with different doses (1, 5, 
and 10  μg/ml) of insulin showed dose-dependent significant 
(p < 0.05) increase in the expression of AKT protein in adipose 
tissue as compare to the control (Figure 6).
effects of In Vitro Treatment of gnih either 
alone Or Together with insulin to the 
adipose Tissue of Mice
The Expression of IR Protein
The adipose tissue treated in vitro with different doses (10−10 and 
10−9M/ml) of GnIH with or without insulin (10 μg/ml) showed 
a dose-dependent significant (p < 0.05) decrease in expression 
of IR protein as compared with the control. The treatment with 
a high dose of GnIH together with insulin showed a significant 
(p < 0.05) increase in the expression of IR protein in the adipose 
tissue as compared with the only GnIH-treated group (Figure 7A).
The Expression of GLUT4 Protein
The adipose tissue treated in vitro with different doses (10−10 and 
10−9M/ml) of GnIH with or without insulin (10 μg/ml) showed a 
FigUre 5 | The in vitro treatment with different doses of insulin (1, 5, 
and 10 μg/ml) on expression of insulin receptor and glUT4 proteins 
in the adipose tissue. The treatment of insulin showed dose-dependent 
significant (b, c and d, p < 0.05) increase in expression of IR (a) and (b and 
c, p < 0.05) GLUT4 (B) proteins in the adipose tissue as compared with the 
control (a, p < 0.05).
FigUre 4 | The in vitro treatment of different doses (10−10 and 10−9M/
ml) of gnih with or without different doses (10 and 100 ng/ml) of lh 
showed effect on glucose uptake by the testis and expression of 
glUT 8 protein. (a) The treatment with low and high doses (10−10 and 
10−9M/ml) of GnIH showed a dose-dependent suppression of glucose uptake 
in the testis. The treatment with low and high (10 and 100 ng/ml) doses of LH 
alone showed a dose-dependent significant (d and e, p < 0.05) increase in 
glucose uptake by the testis. A high dose of LH together with a high dose of 
GnIH showed a significant (f, p < 0.05) increase in uptake of glucose by the 
testis as compared with the control (a, p < 0.05). (B) The treatment with low 
and high doses (10−10 and 10−9M/ml) of GnIH showed a significant  
(b, p < 0.05) decrease in the expression of GLUT8 protein. The treatment 
with low and high doses (10 and 100 ng/ml) of LH showed a dose-
dependent significant (c and d, p < 0.05) increase in the expression of 
GLUT8 protein. A high dose of LH with a high dose of GnIH showed a 
significant (f, p < 0.05) increase in the expression of GLUT8 protein in the 
testis as compared with the control (a, p < 0.05).
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dose-dependent significant (p < 0.05) increase in the expression 
of GLUT 4 protein as compared with the control. The treatment 
with the high dose of GnIH together with insulin showed a 
significant (p <  0.05) increase in the expression of GLUT4 
protein in the adipose tissue as compared with only GnIH-
treated group (Figure 7B).
The Expression of AKT/PBK Protein
The adipose tissue treated in vitro with different doses (10−10 and 
10−9M/ml) of GnIH alone showed a dose-dependent significant 
(p <  0.05) decrease in the expression of AKT protein as com-
pared with the control. The treatment with a high dose of GnIH 
together with insulin showed a significant (p < 0.05) increase in 
the expression of AKT protein in the adipose tissue as compared 
with the only GnIH-treated group (Figure 8).
correlation study
The results of correlation study studies are summarized in Table 4. 
A significant (p < 0.05) correlation was found between changes in 
circulating testosterone levels, glucose levels, and TG levels with 
changes in the rate of expression of GLUT4, GLUT8, and IR in 
adipose tissue and testis of mice treated with GnIH.
FigUre 7 | The in vitro treatment of adipose tissue with different 
doses (10−10 M and 10−9 M/ml) of gnih with or without insulin  
(10 μg/ml) showed (a) a dose-dependent (b and c, p < 0.05) 
significant decrease in expression of ir protein as compared with the 
control with (10−10 M and 10−9 M/ml) of gnih. The treatment with a high 
dose of GnIH together with insulin showed a significant (d, p < 0.05) increase 
in the expression of IR protein in as compared with the only GnIH-treated 
group. (B) The in vitro treatment of adipose tissue with different doses (10−10 
and 10−9M/ml) of GnIH with or without insulin (10 μg/ml) showed a 
dose-dependent significant (p < 0.05) increase in the expression of GLUT 4 
protein as compared with the control. The treatment with the high dose of 
GnIH together with insulin showed a significant (d, p < 0.05) increase in the 
expression of GLUT4 protein in the adipose tissue as compared with only 
GnIH-treated group.
FigUre 6 | The in vitro treatment of adipose tissue with different 
doses (1, 5, and 10 μg/ml) of insulin showed dose-dependent 
significant (b, c, and d, p < 0.05) increase in the expression of aKT/
PKB protein in adipose tissue as compare to the control (a, p < 0.05).
February 2016 | Volume 7 | Article 68
Anjum et al. Role of GnIH in Nutrition and Reproduction
Frontiers in Endocrinology | www.frontiersin.org
DiscUssiOn
For the first time, the results of present study provide the 
experimental proof suggesting an active participation of GnIH in 
increased food intake and glucose and TGs uptake in adipose tis-
sue results in fat accumulation and increased body mass whereas 
in testis, GnIH suppressed glucose uptake resulting in decreased 
testosterone synthesis. In the present study, three different doses of 
GnIH were used, and the results showed dose-dependent changes 
in majority of the studies. But treatment with the high dose of 
GnIH (2 μg/day) showed a significant variation as compared with 
the control, thus the results of high dose of GnIH treatment are 
generally considered for discussion.
The mice treated in vivo with GnIH showed both dose- and 
duration-dependent increase in food intake. High dose of 
RFRP-3 (2 μg/day) showed increased food intake on day 1 itself 
as compared with the control, whereas moderate dose of RFRP-3 
(200  ng/day) showed significant increase in food intake on 
day 4. The lower dose of RFRP-3 did not show any significant 
increases in food intake until day 8 (Table 2). Thus moderate and 
high doses of GnIH induced a significant increase in food intake 
as compared to the control, and it is therefore considered that 
GnIH increases food intake in mice. In addition, the mice treated 
in vivo with GnIH for 8 days showed increased accumulation of 
adipose tissue and body mass as compared to the control. These 
findings are in agreement with earlier observations in chicks 
and rat (32, 43) and suggest that GnIH is one of the orexigenic 
peptide in mammals. An earlier study has demonstrated the 
presence of RFRP-3 receptor (GPR147) in the adipose tissue 
(44). The GnIH containing neurons was shown in contact with 
the neurons containing neuropeptides, such as neuropeptideY, 
pro-opio melanocortin, orexin, and melanopeptide, which are 
known modulators of nutritional changes (28, 45, 46). In an 
earlier study, where rat was treated with GnRH agonist showed a 
dose-dependent gain in the body mass (47). It was suggested that 
GnRH agonist-induced increase in the body mass might be due 
to neuropeptideY- and/or opioidpeptide-mediated increase in 
feeding activity in the rats (48). Accordingly, in the present study, 
GnIH may act as a modulator of energy homeostasis association 
with other neuropeptides in the mice.
FigUre 8 | The in vitro treatment of adipose tissue with different 
doses (10−10 and 10−9M/ml) of gnih alone showed a dose-dependent 
significant (b and c, p < 0.05) decrease in the expression of aKT/PKB 
protein as compared with the control. The treatment with a high dose of 
GnIH together with insulin showed a significant (d, p < 0.05) increase in the 
expression of AKT/PKB protein in the adipose tissue as compared with the 
only GnIH-treated group. Values are mean ± SEM.
TaBle 4 | correlation studies of gnih treatment between the different parameters in adipose tissue and testis (in vivo).
adipose 
tissue 
Tg
serum Tg serum 
glucose
Testicular 
glucose 
level
Testosterone 
level
adipose tissue Testis
glUT4 glUT8 ir glUT8 ir
Adipose 
tissue TG
r = −0.99, 
p < 0.05
r = −0.97, 
p < 0.05
NS NS r = 0.89, 
p < 0.05
r = −0.67, 
p < 0.05
r = −0.57, 
p < 0.05
NS r = 0.57, 
p < 0.05
Serum TG r = 0.98, 
p < 0.05
NS NS r = −0.91, 
p < 0.05
r = 0.67, 
p < 0.05
r = 0.57, 
p < 0.05
NS r = 0.56, 
p < 0.05
Serum 
glucose
NS NS r = −0.93, 
p < 0.05
r = 0.63, 
p < 0.05
NS NS r = −0.56, 
p < 0.05
Testicular 
glucose 
level
r = 0.94, 
p < 0.05
r = 0.63, 
p < 0.05
NS
Testosterone 
level
r = 0.82, 
p < 0.05
r = 0.56, 
p < 0.05
GLUT4 r = −0.97, 
p < 0.05
r = −0.94, 
p < 0.05
NS NS
GLUT8 r = 0.99, 
p < 0.05
NS r = 0.78, 
p < 0.05
NS, not significant.
Values are significantly different at p < 0.05.
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Interestingly, in the present study, in vivo treatment of GnIH 
showed dose-dependent increase in the expression of GLUT4 
protein, but significant decline in the expression of GLUT8 and 
IR proteins in the adipose tissue. GLUT4, a major isoform of 
GLUT, is normally found in the insulin-responsive tissue, such 
as the striated muscle and adipose tissue, and plays a crucial role 
in whole body glucose homeostasis. It is well known that insulin 
upregulates the expression of GLUT4 protein (49, 50). Besides 
GLUT4, GLUT8, and GLUT12 are other GLUTs regulated by 
insulin (51). GLUT8 is mainly expressed in the striated muscle, 
adipose tissue, testis, blastocyst, brain, liver, and kidney (52, 53). 
The upregulation of GLUT4 by GnIH in the adipose tissue is 
unique findings of this study. Despite increased expression of 
GLUT4, GnIH treatment caused dose-dependent downregula-
tion of GLUT8 and IR proteins in the adipose tissue. In adipose 
tissue, expression of GLUT4 is under regulation of insulin, but 
regulation of GLUT8 is not known. This study also showed a 
significant positive correlation between changes in expression 
of IR with GLUT8 protein but showed a negative correlation 
between the changes in expression of IR with GLUT4 protein 
in the adipose tissue treated in vivo with GnIH. This suggests 
that in adipose tissue, expression of GLUT8 protein changes 
with IR level. Furthermore, the in  vitro study confirmed the 
in vivo observations of GnIH-induced upregulation of GLUT4 
together with the downregulation of IR proteins in the adipose 
tissue. These observations thus suggest that GnIH increases 
glucose uptake in the adipose tissue stimulating expression of 
GLUT4.
The in  vivo treatment with high dose of GnIH showed 
significantly increased synthesis of TGs in adipose tissue. GnIH-
induced increased expression of GLUT4 suggests increased 
uptake of glucose into adipose tissue, which subsequently may 
get converted into TG and free fatty acid, the storage form of 
nutrients in the adipocytes. The mice treated with GnIH in vivo 
showed dose-dependent significant decline in the circulating TG 
and glucose levels. Simultaneously with decline in circulating TG 
levels, this study showed significant increase in the TG level in 
the adipose tissue as compared with the control. The significant 
inverse correlation between changes in TG level in the serum 
verses adipose tissue suggest that GnIH may be responsible for 
increased transport of TGs from serum to adipose tissue. This 
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consequently may be responsible for increased accumulation of 
fat in the adipocytes and consequently increase in body mass.
The mice treated in vivo with GnIH showed a dose-dependent 
significant (p  <  0.05) decline in the level of testosterone as 
compared with the control. The earlier study on hamster testes 
revealed the expression of RFRP-receptor (GPR147). Thus, sug-
gesting autocrine or paracrine role of RFRP in testis (54). The 
GnIH treatment in vivo also showed a significant decline in the 
expression of GLUT8 and IR proteins together with decreased 
concentration of glucose in the testis. This finding thus suggests 
that the mice treated with GnIH caused reduced availability of 
glucose to the testis; this consequently may be responsible for the 
decreased testosterone synthesis. This finding further confirms 
our recent study that the decreased availability of glucose to the 
testis resulted in the decreased steroidogenesis (16). It has earlier 
been demonstrated that glucose availability also modulates the 
level of the steroidogenic enzyme nicotinamide adenine dinucleo-
tide phosphate (NADPH) in the testis (55). The in vivo treatment 
of GnIH also caused suppressed expression of IR protein in the 
testis. Since insulin directly affects testicular steroidogenesis via 
the induction of dosage-sensitive sex reversal, adrenal hypoplasia 
critical region, on chromosome X, gene 1 (DAX-1) in Leydig 
cells (56), it possible that GnIH may inhibit steroidogenesis by 
downregulating IR in the testis.
Similar to in vivo study, the testes treated in vitro with GnIH 
also showed significant decreased expression of GLUT8 protein, 
decreased concentration of glucose, and significant decline in 
the testosterone synthesis. These findings thus suggest that the 
GnIH-induced decreased uptake of glucose may be directly 
responsible for the inhibition of testicular steroidogenesis. This 
study confirmed the earlier finding that Leydig cells culture in the 
absence of glucose can synthesis testosterone at very low rate (16, 
57). The testis treated in vitro with LH either alone or together 
with GnIH showed a stimulatory effect on the glucose uptake 
together with the increased expression of GLUT8 protein and 
increased synthesis of testosterone. This study suggests that in 
presence of physiological concentration of LH, inhibitory effect 
of GnIH is suppressed. Our earlier studies have shown that LH or 
hCG increases glucose uptake by increasing GLUT8 expression in 
the testis (16). Thus in the physiological condition, when LH in 
sufficient concentration exist in the plasma, GnIH may facilitate 
glucose uptake by promoting GLUT8 in testis.
To investigate the signaling pathway of GnIH and insulin-
mediated glucose uptake, AKT/PKB levels were evaluated in the 
adipose tissue. The adipose tissue from mice treated with different 
doses of GnIH with or without insulin in vitro showed a significant 
variation in the expression of AKT/PKB protein together with 
the expression of GLUT4 and IR proteins. The GnIH-induced 
changes in GLUT4 levels showed no significant correlation with 
the changes in AKT/PKB levels, but correlated significantly with 
the changes in IR protein. Furthermore, the insulin-induced 
changes in GLUT4 and IR levels correlated significantly with the 
changes in AKT/PKB levels in the adipose tissue. Although AKT/
PKB is involved in many signaling pathways including glucose 
trafficking (58), this finding suggests that AKT/PKB may func-
tion as a signaling molecule in the insulin-induced GLUT4 (59) 
and IR expression as well as in the GnIH-induced IR expression 
in the adipose tissue. But AKT/PKB may not function as a signal-
ing molecule in the GnIH-induced changes in the expression of 
GLUT4 protein in the adipose tissue.
In brief, the results of this study showed differential effect of 
GnIH-induced changes in nutrient levels of the adipose tissue 
and testis of mice. The in  vivo treatment with GnIH showed 
the increased expression of GLUT4 together with increased 
uptake of TGs in the adipose tissue, which in turn resulted in 
the increased accumulation of fat into WAT and increase in 
the body mass. On the contrary in the testis, GnIH treatment 
in vivo caused downregulation of GLUT8 expression resulting 
in the decreased uptake of glucose, which in turn resulted in 
the decreased synthesis of testosterone. The mice treated with 
GnIH also showed the decreased expression of IR protein in 
the testis. The decreased level of IR may be responsible for the 
decreased testicular activity in the mice. The in vitro treatment 
of GnIH to the adipose tissue showed the increased expression 
of GLUT4 suggesting the increased uptake of glucose, despite 
decrease in IR. The in  vitro treatment of GnIH to the testis 
showed decreased expression of GLUT8 protein resulted in 
decreased uptake of glucose and testosterone synthesis. These 
findings thus suggest that GnIH increases nutrients (glucose and 
TGs) uptake in the adipose tissue resulted in accumulation of 
fat, whereas in the testis GnIH suppresses the glucose uptake 
resulted in the decreased testosterone synthesis in mice. This 
study further showed that the insulin-induced upregulation 
of GLUT4 expression may be PKB/AKT mediated, whereas 
GnIH-induced upregulation of GLUT4 is not mediated through 
PKB/AKT mechanisms. On the basis of present study, GnIH 
appears to serve an important role in determining the level of fat 
accumulation in the adipose tissue and accordingly modulating 
the reproductive strategies to be adopted by the animal. Further 
studies are required to find out whether the GnIH is associated 
with decline in testosterone as observed during diabetes mellitus 
type II, aging, or subfertility in men.
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